M.J. Van den Bent provides expert insights on results from studies in CNS malignancies presented at ASCO 2015 Annual Meeting. In particular, he elaborates findings from the study presented at Plenary session on cognitive effects of the whole brain radiation therapy added to radiosurgery in patients with 1 to 3 brain metastases; then discuss on TTF added to standard chemo- and radiotherapy in newly diagnosed glioblastoma and results of radiochemotherapy studies in anaplastic glioma and astrocytoma.

Oncology Meeting Resources

Major Sponsors

AstraZeneca Janssen Lilly Oncology

Main Sponsors

Amgen Astellas Bayer Healthcare Boehringer Ingelheim Daiichi Sankyo Genomic Health Inc. Roche